Multicenter validation study of a treatment selection MAP for pancreatic neuroendocrine tumors.
Masafumi IkedaSusumu HijiokaTetsuhide ItoShigemi MatsumotoYoshitaka HonmaMakoto UenoNaohiro OkanoTaku AokiJunji FurusePublished in: Japanese journal of clinical oncology (2024)
The usefulness of the MAP for treatment selection was validated in the molecular-targeted agent area of the MAP.